Will Amgen buy Horizon?

As a seasoned professional in the realm of cryptocurrency and finance, I must inquire with genuine curiosity: Is there a looming acquisition in the biotech industry, specifically with regards to Amgen potentially purchasing Horizon Therapeutics? This question arises amidst the ever-shifting landscape of mergers and acquisitions, where strategic partnerships and takeovers are crucial drivers of growth and innovation. Given the complementary nature of their portfolios and potential synergies, could such a move potentially reshape the competitive dynamics within the sector? The answer to this query holds significant implications for both companies' shareholders, employees, and the broader healthcare industry at large.